Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 16/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 16/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 16/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 16/20 | 0.40 |
| ▸ | GABRP | O00591 | 14/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 14/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 14/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 14/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 14/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 14/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 14/20 | 0.40 |
| ▸ | GABRE | P78334 | 14/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 14/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 14/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 14/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 14/20 | 0.40 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28139742 | 1.00 | GRIN1 (0.41) | GRIN1GRIN2BGABRDGABRA1GABRB2 | |
| SCHEMBL22072638 | 0.85 | GABRP (0.46) | GRIN1GRIN2BGABRDGABRA1GABRB2 | |
| SCHEMBL4385665 | 0.82 | GRIN1 (0.42) | GRIN1GRIN2BGABRDGABRA1GABRB2 | |
| SCHEMBL22072807 | 0.82 | GRIN1 (0.42) | GRIN1GRIN2BGABRDGABRA1GABRB2 | |
| SCHEMBL20924552 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP | |
| SCHEMBL22782935 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP | |
| SCHEMBL21134625 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP | |
| SCHEMBL19655746 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP | |
| SCHEMBL19655748 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP | |
| SCHEMBL25699273 | 0.81 | GABRA1 (0.62) | GABRDGABRA1GABRB2GABRA4GABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010050941-A1 | CANDLES CONTAINING A HUMAN PHEROMONE COMPONENT | BRAGINSKY PHILIP (US) | 2010-05-06 | — | — | WO | claimed |
| WO-2009032325-A1 | SHAPED ITEMS CONTAINING A HUMAN PHEROMONE COMPONENT | FLOW SCIENCE, INC. (US) | 2009-03-12 | — | — | WO | claimed |
| WO-2007139782-A2 | COATING COMPOSITION CONTAINING A HUMAN PHEROMONE COMPONENT | BRAGINSKY PHILIP Y (US) | 2007-12-06 | — | — | WO | claimed |
| US-20070116742-A1 | Confectionary products containing a human pheromone component | BRAGINSKY PHILIP Y | 2007-05-24 | — | — | US | claimed |
| US-20070116746-A1 | Packaging items containing a human pheromone component | BRAGINSKY PHILIP Y | 2007-05-24 | — | — | US | claimed |
| EP-0891188-A4 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARM INC (US) | 2004-09-01 | — | — | EP | claimed |
| EP-0830369-B1 | NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 2003-05-14 | — | — | EP | claimed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | claimed |
| US-6242619-B1 | BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE | PHERIN PHARMACEUTICALS, INC. | 2001-06-05 | — | — | US | claimed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | claimed |
| US-5792757-A | ANTIFERTILITY AGENTS, ANXIOLYTIC AGENTS | PHERIN PHARMACEUTICALS (US) | 1998-08-11 | — | — | US | claimed |
| WO-1998003207-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | — | 1998-05-22 | — | — | WO | claimed |
| EP-0830369-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | Pherin Pharmaceuticals, Inc. (US) | 1998-03-25 | — | — | EP | claimed |
| WO-1997036596-A9 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | — | 1997-12-04 | — | — | WO | claimed |
| WO-1997036596-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARMACEUTICALS, INC. (US) | 1997-10-09 | — | — | WO | claimed |
| WO-1996040727-A9 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | — | 1997-01-30 | — | — | WO | claimed |
| WO-1996040727-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0001851-B1 | HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS OF STEROIDS AND PROCESSES FOR THEIR PREPARATION | AKZO N.V. (NL) | 1981-11-11 | — | — | EP | claimed |
| US-4177269-A | ANTITUMOR AGENTS | AKTIEBOLAGET LEO (SE) | 1979-12-04 | — | — | US | claimed |
| US-4089852-A | Process for the preparation of 21-hydroxy-16-pregnen-20-one derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-05-16 | — | — | US | claimed |